Skip to main content
. 2019 May 30;8(6):523. doi: 10.3390/cells8060523

Table 3.

Proportion of patients with clinical improvement at week 6 (ITT Population).

IBD98-M 0.8 g/day
(N = 17)
IBD98-M 1.2 g/day (N = 16) Placebo (N = 18)
Clinical Improvement at Week 6 n (%) 3 (17.6) 5 (31.3) 3 (16.7)
95% confidence interval 5.5, 57.2 12.8, 64.9 4.7, 50.8
p value versus placebo >0.999 0.678

Abbreviations: ITT = intent-to-treat; UCDAI = Ulcerative Colitis Disease Activity Index.